Understanding the Evolving Immuno-Oncology Treatment Paradigm in Non-Small-Cell Lung Cancer

Download All
Explore the recent expansion of new data, new indications, and new immunotherapies in the treatment of NSCLC with this comprehensive educational program featuring an on-demand webcast and downloadable slides from a live CCO webinar as well as an FAQ podcast and expert-authored commentary highlighting new data from WCLC Virtual 2021.
Julie Brahmer, MD, MSc
person default
Jarushka Naidoo, MB BCH BAO, MHS

Downloadable Slidesets

Download these slides from a live CCO Webinar for an overview of the evolving immunotherapy landscape for advanced or metastatic NSCLC, including for special populations.

Julie Brahmer, MD, MSc person default Jarushka Naidoo, MB BCH BAO, MHS Released: September 17, 2021

Download these slides from a live CCO Webinar for an overview of the evolving immunotherapy landscape for early-stage resectable and stage III unresectable NSCLC.

person default Jarushka Naidoo, MB BCH BAO, MHS Released: September 17, 2021

Download this short summary slideset of key takeaways from a live CCO Webinar on immunotherapy for the treatment of patients across the spectrum of NSCLC.

Julie Brahmer, MD, MSc person default Jarushka Naidoo, MB BCH BAO, MHS Released: September 23, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Genentech, a member of the Roche Group
Helsinn Healthcare SA
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue